IL6 and congenital rubella syndrome: Figure 2 demonstrates laboratory response for CRP and IL-6 with variable dynamics of ferritin and lymphocytes in all CS-free treatment episodes, indicating CS-independent anti-inflammatory activity of Rux in COVID-19 induced CRS.